FDA Issues CRL for Roluperidone in the Treatment of Negative Symptoms of Schizophrenia

The CRL cited several areas for clinical improvement necessary for future approval of the treatment.

Related Keywords

New Hampshire ,United States ,Exeter Hospital ,Massachusetts ,Johnj Miller ,Remy Luthringer ,Us Food Drug Administration ,Insight Meditation Society ,Staff Psychiatrist At Seacoast Mental Health Center ,Minerva Neurosciences Inc ,Brain Health ,Drug Administration ,Complete Response Letter ,New Drug Application ,Psychiatric Times ,Medical Director ,Staff Psychiatrist ,Seacoast Mental Health Center ,Consulting Psychiatrist ,